JILL MILLER: Open Payments
NPI 1063792026 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 47 payments from 9 companies in 2025. Trend: 2023 $479 · 2024 $226 · 2025 $955
Food & beverage: $655Consulting: $300
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 31 | $346 |
| Biogen, Inc. | 5 | $245 |
| JAZZ PHARMACEUTICALS INC. | 2 | $170 |
| ABBVIE INC. | 2 | $52 |
| Axsome Therapeutics, Inc. | 3 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| 3B Medical, Inc. | 1 | $21 |
Products named: NURTEC ODT, XYWAV, TYSABRI, VUMERITY, QULIPTA, Sunosi, KESIMPTA, Dysport.
Industry payments across IA — which companies pay providers there.
